BioTechnology HOMERUN potentials
I 'd bought and sold Dendreon Corp (NASDAQ:DNDN) several times in my IRA's. The first time I recommended DNDN here was 02/05/2009 and my start price was $3.56 ... yep, $3.56. I rec'd DNDN because I was certain a positive outcome was close. I closed my real world and MFool DNDN picks on 4/13/2009 @ $7.34 for a nice gain in a little over 2 months, vs the S&P's SPY, of 104.30 %. The next day ... the positive outcome I was expecting sent DNDN through the roof ... DNDN opened at $21.40 ... hit a intraday high of $22.1 ... and closed at $16.99.
Smiling, ... I'm not complaining. I LOCKED in a gain. Yep, I missed out on the further runs to the upside in DNDN ... but I haven't been sitting on my hands. My new 100 star BioTechnology pick with HOMERUN potential is Neuralstem Inc. (CUR). Neuralstem has studies going on in Germany and the USA for different afflictions. Neuralstem has recently come to the attention of the press due a report (favorable) by the University Hospital at a conference in France.
Check out the recent article: " Neuralstem's ALS Stem Cell Treatment Featured on CNN "
April 30, 2010 11:18 AM ET ROCKVILLE, Md., April 30 /PRNewswire-FirstCall/ --
For the rest of the story:
and a video news report: " CNN's Dr. Sanjay Gupta reports on a new stem cell clinical trial that is making history. " For the video ....
and under Health: " Stem cell Medical Breakthrough?"
also, check out the Motley Fool CUR quote and comment page. There's only seven of us now.